Marijuana Research Today is a free monthly online journal that collates and summarizes the latest research about Marijuana, including details on benefits, cancer, effects, uses, addiction.

Volume 5 (2008), Issue 5 (May)

1. A role for p53 in the regulation of lysosomal permeability by delta 9-tetrahydrocannabinol in rat cortical neurones: implications for neurodegeneration.
   J Neurochem, 105(4): 1513-24. [Abstract] [Full-text]
2. Vicarious exposure to terrorist attacks and substance use: results from an urban household survey.
   J Urban Health, 85(3): 411-27. [Abstract] [Full-text]
3. Sexual victimization and health-risk behaviors: a prospective analysis of college women.
   J Interpers Violence, 23(6): 744-63. [Abstract] [Full-text]
4. Early exposure to cannabis and risk for psychosis in young adolescents in Trinidad.
   Acta Psychiatr Scand. [Abstract] [Full-text]
5. National young-driver survey: teen perspective and experience with factors that affect driving safety.
   Pediatrics, 121(5): e1391-403. [Abstract] [Full-text]
6. The adolescent cannabis check-up: randomized trial of a brief intervention for young cannabis users.
   J Subst Abuse Treat, 34(4): 407-14. [Abstract] [Full-text]
7. School-based prevention for illicit drugs use: A systematic review.
   Prev Med, 46(5): 385-96. [Abstract] [Full-text]
8. Universal screening for substance abuse at the time of parturition.
   Am J Obstet Gynecol, 198(5): e30-2. [Abstract] [Full-text]
9. Role of individual, peer and family factors in the use of cannabis and other illicit drugs: A longitudinal analysis among Finnish adolescent twins.
   Drug Alcohol Depend. [Abstract] [Full-text]
10. Co-morbid pain and psychopathology in males and females admitted to treatment for opioid analgesic abuse.
    Pain. [Abstract] [Full-text]
11. JunD is involved in the antiproliferative effect of Delta(9)-tetrahydrocannabinol on human breast cancer cells.
    Oncogene. [Abstract] [Full-text]
12. Enhancing prediction of inhalant abuse risk in samples of early adolescents: a secondary analysis.
    Addict Behav, 33(7): 895-905. [Abstract] [Full-text]
13. Adolescent ecstasy and other drug use in the National Survey of Parents and Youth: the role of sensation-seeking, parental monitoring and peer's drug use.
    Addict Behav, 33(7): 919-33. [Abstract] [Full-text]
14. The influence of attitudes, acculturation, and gender on substance use for Mexican American middle school students.
    Addict Behav, 33(7): 949-54. [Abstract] [Full-text]
15. Substance use disorders among inhalant users: results from the National Epidemiologic Survey on alcohol and related conditions.
    Addict Behav, 33(7): 968-73. [Abstract] [Full-text]
16. Pill-poppers and dopers: a comparison of non-medical prescription drug use and illicit/street drug use among college students.
    Addict Behav, 33(7): 934-41. [Abstract] [Full-text]
17. Detrimental psychophysiological effects of early maternal deprivation in adolescent and adult rodents: Altered responses to cannabinoid exposure.
    Neurosci Biobehav Rev. [Abstract] [Full-text]
18. Endocannabinoids and liver disease. IV. Endocannabinoid involvement in obesity and hepatic steatosis.
    Am J Physiol Gastrointest Liver Physiol, 294(5): G1101-4. [Abstract] [Full-text]
19. Five-Factor Model personality profiles of drug users.
    BMC Psychiatry, 8: 22. [Abstract] [Full-text]
20. Effects of THC on driving performance, physiological state and subjective feelings relative to alcohol.
    Accid Anal Prev, 40(3): 926-34. [Abstract] [Full-text]
21. Limits of the quasi-induced exposure method when compared with the standard case-control design Application to the estimation of risks associated with driving under the influence of cannabis or alcohol.
    Accid Anal Prev, 40(3): 861-868. [Abstract] [Full-text]
22. Is there evidence for symptoms of cannabis withdrawal in the national epidemiologic survey of alcohol and related conditions?
    Am J Addict, 17(3): 199-208. [Abstract] [Full-text]
23. Is attention deficit hyperactivity disorder (ADHD) symptom severity associated with tobacco use?
    Am J Addict, 17(3): 195-8. [Abstract] [Full-text]
24. Characterisation of the cannabinoid receptor system in synovial tissue and fluid in patients with osteoarthritis and rheumatoid arthritis.
    Arthritis Res Ther, 10(2): R43. [Abstract] [Full-text]
25. Does the 'gateway' matter? Associations between the order of drug use initiation and the development of drug dependence in the National Comorbidity Study Replication.
    Psychol Med. [Abstract] [Full-text]
26. Abstinent adolescent marijuana users show altered fMRI response during spatial working memory.
    Psychiatry Res, 163(1): 40-51. [Abstract] [Full-text]
27. Disease progression in chronic hepatitis C: modifiable and nonmodifiable factors.
    Gastroenterology, 134(6): 1699-714. [Abstract] [Full-text]
28. Motor vehicle collisions and their demographics: a 5-year retrospective study of the hamilton-wentworth niagara region.
    J Forensic Sci, 53(3): 709-15. [Abstract] [Full-text]
29. Risk behaviours and blood borne virus exposure for transient workers in rural Victoria.
    Aust J Rural Health, 16(3): 143-9. [Abstract] [Full-text]
30. The cannabinoid delta-9-tetrahydrocannabinol mediates inhibition of macrophage chemotaxis to RANTES/CCL5: linkage to the CB2 receptor.
    J Neuroimmune Pharmacol, 3(2): 117-29. [Abstract] [Full-text]
31. Heavy marijuana users show increased serum apolipoprotein C-III levels: evidence from proteomic analyses.
    Mol Psychiatry. [Abstract] [Full-text]
32. Cannabis, cannabinoids and schizophrenia: integration of the evidence.
    Aust N Z J Psychiatry, 42(5): 357-68. [Abstract] [Full-text]
33. Cannabis reinforcement and dependence: role of the cannabinoid CB1 receptor.
    Addict Biol, 13(2): 188-95. [Abstract] [Full-text]
34. Activation of cannabinoid-1 receptors disrupts sensory gating and neuronal oscillation: relevance to schizophrenia.
    Biol Psychiatry, 63(11): 1075-83. [Abstract] [Full-text]
35. Plant-derived cannabinoids modulate the activity of transient receptor potential channels of ankyrin type-1 and melastatin type-8.
    J Pharmacol Exp Ther, 325(3): 1007-15. [Abstract] [Full-text]
36. The endocannabinoid system: emotion, learning and addiction.
    Addict Biol, 13(2): 196-212. [Abstract] [Full-text]
37. Cannabis and psychiatric disorders: it is not only addiction.
    Addict Biol, 13(2): 264-75. [Abstract] [Full-text]
38. Puberty as a highly vulnerable developmental period for the consequences of cannabis exposure.
    Addict Biol, 13(2): 253-63. [Abstract] [Full-text]
39. Ligands that target cannabinoid receptors in the brain: from THC to anandamide and beyond.
    Addict Biol, 13(2): 147-59. [Abstract] [Full-text]
40. The association between cannabis abuse and dependence and childhood physical and sexual abuse: evidence from an offspring of twins design.
    Addiction, 103(6): 990-7. [Abstract] [Full-text]
41. Cannabis use and later life outcomes.
    Addiction, 103(6): 969-76; discussion 977-8. [Abstract] [Full-text]
42. Advances in the field of cannabinoid--opioid cross-talk.
    Addict Biol, 13(2): 213-24. [Abstract] [Full-text]
43. The pharmacology of the endocannabinoid system: functional and structural interactions with other neurotransmitter systems and their repercussions in behavioral addiction.
    Addict Biol, 13(2): 160-87. [Abstract] [Full-text]
44. Substance use outcomes 51/2 years past baseline for partnership-based, family-school preventive interventions.
    Drug Alcohol Depend, 96(1): 57-68. [Abstract] [Full-text]
45. Diagnostic orphans for alcohol use disorders in a treatment-seeking psychiatric sample.
    Drug Alcohol Depend, 96(1): 187-91. [Abstract] [Full-text]
46. The developmental antecedents of illicit drug use: evidence from a 25-year longitudinal study.
    Drug Alcohol Depend, 96(1): 165-77. [Abstract] [Full-text]
47. DSM-IV criteria-based clinical subtypes of cannabis use disorders: results from the National Epidemiological Survey on Alcohol and Related Conditions (NESARC).
    Drug Alcohol Depend, 96(1): 136-44. [Abstract] [Full-text]
48. Activation of the endocannabinoid system by organophosphorus nerve agents.
    Nat Chem Biol, 4(6): 373-8. [Abstract] [Full-text]
49. Toward a needs-based typology of homeless youth.
    J Adolesc Health, 42(6): 549-54. [Abstract] [Full-text]
50. Impact of maternal substance abuse and smoking on children with gastroschisis.
    J Pediatr Surg, 43(5): 879-83. [Abstract] [Full-text]
51. Attempts to stop or reduce marijuana use in non-treatment seekers.
    Drug Alcohol Depend. [Abstract] [Full-text]
52. Cannabis use and genetic predisposition for schizophrenia: a case-control study.
    Psychol Med. [Abstract] [Full-text]
53. In situ analysis of cell wall polymers associated with phloem fibre cells in stems of hemp, Cannabis sativa L.
    Planta, 228(1): 1-13. [Abstract] [Full-text]
54. Role of CYP3A5 in abnormal clearance of methadone.
    Ann Pharmacother, 42(6): 893-7. [Abstract] [Full-text]
55. Feeding induced by cannabinoids is mediated independently of the melanocortin system.
    PLoS ONE, 3(5): e2202. [Abstract] [Full-text]
56. Among long-term crack smokers, who avoids and who succumbs to cocaine addiction?
    Drug Alcohol Depend. [Abstract] [Full-text]
57. Evaluation of cannabinoid agonists using punished responding and midazolam discrimination procedures in squirrel monkeys.
    Psychopharmacology (Berl), 198(4): 521-8. [Abstract] [Full-text]
58. Effects of haloperidol on the behavioral, subjective, cognitive, motor, and neuroendocrine effects of Delta-9-tetrahydrocannabinol in humans.
    Psychopharmacology (Berl), 198(4): 587-603. [Abstract] [Full-text]
59. Immunomodulatory lipids in plants: plant Fatty Acid amides and the human endocannabinoid system.
    Planta Med, 74(6): 638-50. [Abstract] [Full-text]
60. A regiodivergent synthesis of ring a C-prenylflavones.
    Org Lett, 10(11): 2267-70. [Abstract] [Full-text]
61. Effects of perinatal exposure to delta-9-tetrahydrocannabinol on the emotional reactivity of the offspring: a longitudinal behavioral study in Wistar rats.
    Psychopharmacology (Berl), 198(4): 529-37. [Abstract] [Full-text]
62. Recovery and URICA stage-of-change scores in three marijuana treatment studies.
    J Subst Abuse Treat. [Abstract] [Full-text]
63. Perinatal delta-9-tetrahydrocannabinol exposure disrupts social and open field behavior in adult male rats.
    Neurotoxicol Teratol, 30(3): 213-9. [Abstract] [Full-text]
64. Assessing changes in pupillary size in Rifian smokers of kif (Cannabis sativa L.).
    J Forensic Leg Med, 15(5): 335-8. [Abstract] [Full-text]

© 2004-2008 Marijuana Research Today. All Rights Reserved.